Scholarlink

<p>American cutaneous leishmaniasis (ACL) comprises a complex spectrum of immunopathological conditions in which <i>Leishmania (V.) braziliensis</i> and <i>L. (L.) amazonensis</i> elicit markedly divergent host responses. Mucosal leishmaniasis (ML) is characterized by a hyperergic, pro-inflammatory state, whereas anergic diffuse cutaneous leishmaniasis (ADCL) involves a profound impairment of cell-mediated immunity, respectively. The molecular sensors and metabolic circuits that dictate this immunological divergence remain poorly understood. We hypothesized that parasite species-specific programs orchestrate distinct macrophage polarization states, leading either tissue destruction or parasite persistence. We performed transcriptomic profiling (RNA-seq) of skin and mucosal biopsies from 20 ACL patients representing the full clinical spectrum (ADCL, ML, and localized forms) and from healthy controls. Computational deconvolution and gene regulatory network analyses were integrated with immunohistochemical validation of macrophage state markers. Unsupervised clustering identified parasite species as the principal determinant of lesion transcriptomes. ADCL lesions displayed a distinct <i>MARCO</i>-high immunometabolic program associated with upregulation of <i>PPARG</i>, <i>SCARB1</i>, and <i>LRP1</i>, consistent with enhanced fatty acid uptake and oxidative phosphorylation. The immunopathological analyses demonstrated that this signature was associated with a regulatory/anti-inflammatory (M2-like) macrophage phenotype (CD163⁺/IL-10⁺) in ADCL, whereas ML was characterized by an inflammatory (M1-like) macrophage phenotype (CD68⁺/iNOS⁺/TNF-α⁺/IFN-γ⁺). These findings indicate that <i>MARCO</i> expression and macrophage polarization vary markedly across clinical forms of ACL and are strongly influenced by <i>Leishmania</i> species. This interaction promotes immunometabolic reprogramming that supports <i>L. (L.) amazonensis</i> persistence in ADCL, or proinflammatory responses associated with tissue damage in ML due to <i>L. (V.) braziliensis</i>. These processes highlight potential targets for immunotherapeutic strategies aimed at restoring host immunity in severe ACL.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transcriptomic and macrophage polarization signatures define anergic diffuse and mucosal forms of severe American cutaneous leishmaniasis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月18日

查看全文
  • C. M. C. Gomes,
  • L. S. Alcantara,
  • M. B. Campos,
  • V. L. da Matta,
  • K. P. Lundquist,
  • M. A. F. Igreja,
  • A. C. S. Lima,
  • S. M. Oba-Shinjo,
  • A. N. A. Gonçalves,
  • M. D. Laurenti,
  • C. E. Corbett,
  • H. I. Nakaya,
  • F. T. Silveira

摘要

American cutaneous leishmaniasis (ACL) comprises a complex spectrum of immunopathological conditions in which Leishmania (V.) braziliensis and L. (L.) amazonensis elicit markedly divergent host responses. Mucosal leishmaniasis (ML) is characterized by a hyperergic, pro-inflammatory state, whereas anergic diffuse cutaneous leishmaniasis (ADCL) involves a profound impairment of cell-mediated immunity, respectively. The molecular sensors and metabolic circuits that dictate this immunological divergence remain poorly understood. We hypothesized that parasite species-specific programs orchestrate distinct macrophage polarization states, leading either tissue destruction or parasite persistence. We performed transcriptomic profiling (RNA-seq) of skin and mucosal biopsies from 20 ACL patients representing the full clinical spectrum (ADCL, ML, and localized forms) and from healthy controls. Computational deconvolution and gene regulatory network analyses were integrated with immunohistochemical validation of macrophage state markers. Unsupervised clustering identified parasite species as the principal determinant of lesion transcriptomes. ADCL lesions displayed a distinct MARCO-high immunometabolic program associated with upregulation of PPARG, SCARB1, and LRP1, consistent with enhanced fatty acid uptake and oxidative phosphorylation. The immunopathological analyses demonstrated that this signature was associated with a regulatory/anti-inflammatory (M2-like) macrophage phenotype (CD163⁺/IL-10⁺) in ADCL, whereas ML was characterized by an inflammatory (M1-like) macrophage phenotype (CD68⁺/iNOS⁺/TNF-α⁺/IFN-γ⁺). These findings indicate that MARCO expression and macrophage polarization vary markedly across clinical forms of ACL and are strongly influenced by Leishmania species. This interaction promotes immunometabolic reprogramming that supports L. (L.) amazonensis persistence in ADCL, or proinflammatory responses associated with tissue damage in ML due to L. (V.) braziliensis. These processes highlight potential targets for immunotherapeutic strategies aimed at restoring host immunity in severe ACL.